| Address: | 209 Oak Park Blvd, Oakville, ON L6H 7S8, Canada |
|---|---|
| Postal code: | L6H 7S8 |
| Phone: | (905) 602-5840 |
| Website: | http://epuris.ca/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Cipher Pharmaceuticals Inc., use the form below and your opinion, advice or comment will appear in this space.
Cipher Pharmaceuticals Inc. 209 Oak Park Blvd. Suite 501 Oakville, ON L6H 0M2 Phone: (905) 602-5840 info@cipherpharma.com
Situated at 100A-2345 Argentia Rd in Mississauga, Cipher Pharmaceuticals Inc is a merchant inside the pharmaceutical products - wholesalers &/or manufacturers section of Canpages.ca online directory. Feel free to call 905-602-5840 to contact Cipher Pharmaceuticals Inc that is close to your area.
Cipher Pharmaceuticals Inc is a privately held company in Mississauga, ON . ... Phone: (905) 602-5840. View Contact Info. Name: Larry Andrews Job Title: President.
Cipher Pharmaceuticals Inc. Mailing Address: ... 905 602-5840: Reporting Jurisdictions: All provinces and territories of Canada: Fax Number: 905 602-0628:
p: 905-602-5840 F: 905-602-0628 Cipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products.
905-602-5840. www.cipherpharma.com. ... Cipher Pharmaceuticals Inc. announced that its new drug submission for plecanatide for irritable bowel syndrome with constipation has been accepted by ...
SOURCE: Cipher Pharmaceuticals Inc. To obtain a copy of the early warning report filed by Cipher in connection with the Acquisition, please contact Stephen Lemieux at (905) 602-5840 or refer to ...
Cipher Pharmaceuticals Inc provides regulatory approval of prescription medications utilizing drug delivery technologies or new pharmaceuticals. ... 1-905-602-5840. Website www.cipherpharma.com ...
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company, focused on Dermatology. The firm and its subsidiaries develop and acquire products that fulfill unmet medical needs and manage the required clinical development and regulatory process.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company that commercializes novel formulations of marketed molecules. The company focuses on in-licensing clearly differentiated products, advancing them through the clinical development and regulatory approval stages, and either out-licensing to marketing partners or the company may market the product on its own.